{
	"columns": [
		{
			"label": "SimilarStudyID",
			"field": "SimilarStudyID"
		},
		{
			"label": "Title",
			"field": "Title"
		},
		{
			"label": "StudyLink",
			"field": "StudyLink"
		}
    ],
	
	"rows":[
   {
      "SimilarStudyID":"NCT01780545",
      "Title":"The Borealis-2 Clinical Trial: A Randomized Phase 2 Study Comparing Docetaxel Alone to Docetaxel in Combination With OGX-427 in Patients With Relapsed or Refractory Metastatic Urothelial Carcinoma After Receiving a Platinum-containing Regimen: Hoosier Cancer Research Network GU12-160",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT01780545"
   },
   {
      "SimilarStudyID":"NCT02560584",
      "Title":"A Prospective, Open, Comparative, Within Patient Controlled Multicenter Phase 3 Study of Blue Light Cystoscopy With Cysview and White Light Cystoscopy Using KARL STORZ D-Light C PDD Flexible Videoscope System in Detection of Bladder Cancer in Patients With Bladder Cancer",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT02560584"
   },
   {
      "SimilarStudyID":"NCT00233402",
      "Title":"A Randomized, Comparative, Controlled Phase III, Multicenter Study of Hexvix Fluorescence Cystoscopy and White Light Cystoscopy in the Detection Of Papillary Bladder Cancer and the Early Recurrence Rate in Patients With Bladder Cancer",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00233402"
   },
   {
      "SimilarStudyID":"NCT02351739",
      "Title":"Randomized Phase 2 Trial of ACP-196 and Pembrolizumab Immunotherapy Dual CHECKpoint Inhibition In Platinum Resistant Metastatic Urothelial Carcinoma (RAPID CHECK Study)",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT02351739"
   },
   {
      "SimilarStudyID":"NCT03159143",
      "Title":"A Phase II, Single-arm Study of Docetaxel and Oxaliplatin in Metastatic Cisplatin-resistant Transitional Cell Carcinoma of the Urinary Bladder",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT03159143"
   },
   {
      "SimilarStudyID":"NCT02529553",
      "Title":"A Phase 1 Study of LY3076226, a Fibroblast Growth Factor Receptor 3 (FGFR3) Antibody-Drug Conjugate, in Patients With Advanced or Metastatic Cancer",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT02529553"
   },
   {
      "SimilarStudyID":"NCT01520038",
      "Title":"Feasibility and Phase 1/II Trial of Adjuvant Radiation Therapy for the Treatment of Urothelial Bladder Cancer Using Proton Therapy or IMRT",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT01520038"
   },
   {
      "SimilarStudyID":"NCT00710970",
      "Title":"H-16848 - Phase II Pilot Study With Correlative Markers of Tamoxifen for Progressive Transitional Cell Carcinoma Following Previous Chemotherapy",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00710970"
   },
   {
      "SimilarStudyID":"NCT00722553",
      "Title":"A Phase 2, Single-Arm Study of Pralatrexate in Patients With Advanced or Metastatic Relapsed Transitional Cell Carcinoma of the Urinary Bladder",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00722553"
   },
   {
      "SimilarStudyID":"NCT00471536",
      "Title":"A Phase II Safety and Efficacy Study With the VEGF Receptor Tyrosine Kinase Inhibitor GW786034 in Patients With Metastatic Urothelial Cancer",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00471536"
   },
   {
      "SimilarStudyID":"NCT00666562",
      "Title":"A Phase II Randomized, Placebo-Controlled Trial of Polyphenon E to Evaluate Bladder Tissue Levels of EGCG",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00666562"
   },
   {
      "SimilarStudyID":"NCT02233842",
      "Title":"Cognitive Testing of Tobacco Use Measurement Items for Administration With Cancer Patients and Survivors",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT02233842"
   },
   {
      "SimilarStudyID":"NCT00666978",
      "Title":"Enhancing Tobacco Use Treatment for African American Light Smokers",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00666978"
   },
   {
      "SimilarStudyID":"NCT01328574",
      "Title":"A Phase II Study of TRC105 in Adults With Advanced/Metastatic Urothelial Carcinoma",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT01328574"
   },
   {
      "SimilarStudyID":"NCT00397488",
      "Title":"Phase II Study of Sunitinib in Metastatic Transitional Cell Carcinoma of the Urothelium",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00397488"
   },
   {
      "SimilarStudyID":"NCT01108055",
      "Title":"A Phase II Study of Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT01108055"
   },
   {
      "SimilarStudyID":"NCT00880334",
      "Title":"Randomized Study of Docetaxel +/- Vandetanib in Metastatic TCC",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00880334"
   },
   {
      "SimilarStudyID":"NCT00496860",
      "Title":"Phase I Study of ALT-801 in Patients With Progressive Metastatic Malignancies",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00496860"
   },
   {
      "SimilarStudyID":"NCT00526656",
      "Title":"Phase II Single Arm, Open Label, Single Institution Study of Neoadjuvant Sunitinib (SUTENT) in Patients With Muscle-Invasive Locally Advanced Transitional Cell Carcinoma of the Bladder",
      "StudyLink":"https://clinicaltrials.gov/ct2/show/results/NCT00526656"
   }
]
}